======= ZNF592 ======= == Gene Information == * **Official Symbol**: ZNF592 * **Official Name**: zinc finger protein 592 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9640|9640]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92610|Q92610]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZNF592&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZNF592|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613624|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is thought to play a role in a complex developmental pathway and the regulation of genes involved in cerebellar development. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia. [provided by RefSeq, Jan 2011]. * **UniProt Summary**: May be involved in transcriptional regulation. No Pfam Domain information is available for this gene. |DNA binding| |DNA-binding transcription factor activity, RNA polymerase II-specific| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|-1.74| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|1.72| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|1.72| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|1.73| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|1.76| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|1.77| |[[:results:exp515|PU-H71 1μM R08 exp515]]|1.78| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.79| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|1.8| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|1.81| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.86| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|1.89| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|1.94| |[[:results:exp443|SNS-032 15μM R08 exp443]]|1.97| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.02| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|2.1| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|2.13| |[[:results:exp517|Quercetin 20μM R08 exp517]]|2.17| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.23| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.25| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|2.29| |[[:results:exp59|UMK57 1μM R01 exp59]]|2.33| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|2.34| |[[:results:exp350|Deferoxamine 11μM R07 exp350]]|2.35| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|2.4| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|2.42| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|2.5| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|2.73| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|2.95| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|3.13| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|3.75| ^Gene^Correlation^ |[[:human genes:m:med23|MED23]]|0.619| |[[:human genes:w:wdr24|WDR24]]|0.582| |[[:human genes:b:brpf1|BRPF1]]|0.574| |[[:human genes:i:id3|ID3]]|0.573| |[[:human genes:t:trim28|TRIM28]]|0.563| |[[:human genes:m:mllt1|MLLT1]]|0.559| |[[:human genes:f:fbxo11|FBXO11]]|0.552| |[[:human genes:m:med13l|MED13L]]|0.551| |[[:human genes:r:rptor|RPTOR]]|0.512| |[[:human genes:d:dohh|DOHH]]|0.508| |[[:human genes:c:ctdspl2|CTDSPL2]]|0.498| |[[:human genes:m:maml1|MAML1]]|0.495| |[[:human genes:a:actb|ACTB]]|0.492| |[[:human genes:b:bap1|BAP1]]|0.491| |[[:human genes:c:ccdc101|CCDC101]]|0.483| |[[:human genes:n:nsd1|NSD1]]|0.483| |[[:human genes:t:taf5l|TAF5L]]|0.476| |[[:human genes:z:zmynd8|ZMYND8]]|0.475| |[[:human genes:u:usp22|USP22]]|0.465| |[[:human genes:s:setdb1|SETDB1]]|0.463| |[[:human genes:m:med13|MED13]]|0.463| |[[:human genes:t:trim33|TRIM33]]|0.46| |[[:human genes:m:mtor|MTOR]]|0.456| |[[:human genes:a:atf7ip|ATF7IP]]|0.451| |[[:human genes:z:znf608|ZNF608]]|0.45| |[[:human genes:l:lamtor4|LAMTOR4]]|0.445| |[[:human genes:s:sp3|SP3]]|0.44| |[[:human genes:c:celf1|CELF1]]|0.44| |[[:human genes:s:spin1|SPIN1]]|0.438| |[[:human genes:t:tle4|TLE4]]|0.436| |[[:human genes:c:cbfb|CBFB]]|0.435| |[[:human genes:h:hhex|HHEX]]|0.431| |[[:human genes:k:khdrbs1|KHDRBS1]]|0.431| |[[:human genes:s:sox7|SOX7]]|0.426| |[[:human genes:k:kat2a|KAT2A]]|0.426| |[[:human genes:w:wdr59|WDR59]]|0.424| |[[:human genes:m:mios|MIOS]]|0.423| |[[:human genes:v:vhl|VHL]]|0.421| |[[:human genes:e:ehmt2|EHMT2]]|0.42| |[[:human genes:r:runx1|RUNX1]]|0.419| |[[:human genes:t:thoc6|THOC6]]|0.413| |[[:human genes:s:supt7l|SUPT7L]]|0.413| |[[:human genes:s:slc4a7|SLC4A7]]|0.412| |[[:human genes:m:med16|MED16]]|0.41| |[[:human genes:m:mlst8|MLST8]]|0.409| |[[:human genes:s:scaf8|SCAF8]]|0.406| |[[:human genes:e:elf2|ELF2]]|0.406| |[[:human genes:f:fli1|FLI1]]|0.404| |[[:human genes:s:sirt7|SIRT7]]|0.403| |[[:human genes:i:irf2bp2|IRF2BP2]]|0.401| |[[:human genes:a:ahcyl1|AHCYL1]]|0.401| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 517 * **Expression level (log2 read counts)**: 6.67 {{:chemogenomics:nalm6 dist.png?nolink |}}